Ultragenyx price target lowered to $102 from $105 at JPMorgan
JPMorgan lowered the firm’s price target on Ultragenyx (RARE) to $102 from $105 and keeps an Overweight rating on the shares. The firm updated ...
Ultragenyx price target raised to $121 from $109 at Canaccord
Canaccord raised the firm’s price target on Ultragenyx (RARE) to $121 from $109 and keeps a Buy rating on the shares. The firm said they ...
Yahoo Finance27 天
Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate ...
NOVATO, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for ...